These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Dronabinol versus megestrol acetate versus combination therapy for cancer-associated anorexia: a North Central Cancer Treatment Group study. Jatoi A; Windschitl HE; Loprinzi CL; Sloan JA; Dakhil SR; Mailliard JA; Pundaleeka S; Kardinal CG; Fitch TR; Krook JE; Novotny PJ; Christensen B J Clin Oncol; 2002 Jan; 20(2):567-73. PubMed ID: 11786587 [TBL] [Abstract][Full Text] [Related]
3. Cannabinoids in the treatment of symptoms in cancer and AIDS #93. Wilner LS; Arnold RM J Palliat Med; 2006 Jun; 9(3):802-4. PubMed ID: 16752986 [No Abstract] [Full Text] [Related]
4. Comparative efficacy of dronabinol and megestrol acetate. Reynolds R J Clin Oncol; 2002 Jun; 20(12):2912-3; author reply 2913. PubMed ID: 12065574 [No Abstract] [Full Text] [Related]
5. Dronabinol as a treatment for anorexia associated with weight loss in patients with AIDS. Beal JE; Olson R; Laubenstein L; Morales JO; Bellman P; Yangco B; Lefkowitz L; Plasse TF; Shepard KV J Pain Symptom Manage; 1995 Feb; 10(2):89-97. PubMed ID: 7730690 [TBL] [Abstract][Full Text] [Related]
9. Anorexia of aging in long term care: is dronabinol an effective appetite stimulant?--a pilot study. Wilson MM; Philpot C; Morley JE J Nutr Health Aging; 2007; 11(2):195-8. PubMed ID: 17435963 [TBL] [Abstract][Full Text] [Related]
10. The efficacy and tolerability of long-term use of dronabinol in cancer-related anorexia: a case series. Walsh D; Kirkova J; Davis MP J Pain Symptom Manage; 2005 Dec; 30(6):493-5. PubMed ID: 16376734 [No Abstract] [Full Text] [Related]
11. A phase II study of delta-9-tetrahydrocannabinol for appetite stimulation in cancer-associated anorexia. Nelson K; Walsh D; Deeter P; Sheehan F J Palliat Care; 1994; 10(1):14-8. PubMed ID: 8035251 [TBL] [Abstract][Full Text] [Related]
12. A placebo-controlled double blind trial of etanercept for the cancer anorexia/weight loss syndrome: results from N00C1 from the North Central Cancer Treatment Group. Jatoi A; Dakhil SR; Nguyen PL; Sloan JA; Kugler JW; Rowland KM; Soori GS; Wender DB; Fitch TR; Novotny PJ; Loprinzi CL Cancer; 2007 Sep; 110(6):1396-403. PubMed ID: 17674351 [TBL] [Abstract][Full Text] [Related]
13. Use of orexigenic medications in geriatric patients. Thomas DR Am J Geriatr Pharmacother; 2011 Apr; 9(2):97-108. PubMed ID: 21565709 [TBL] [Abstract][Full Text] [Related]
14. From the Food and Drug Administration. Nightingale SL JAMA; 1993 Mar; 269(11):1361. PubMed ID: 8382752 [No Abstract] [Full Text] [Related]
15. The effect of megestrol acetate on anorexia, weight loss and cachexia in cancer and AIDS patients (review). Strang P Anticancer Res; 1997; 17(1B):657-62. PubMed ID: 9066597 [TBL] [Abstract][Full Text] [Related]
16. Treating malnutrition with megestrol acetate: literature review and review of our experience. Karcic E; Philpot C; Morley JE J Nutr Health Aging; 2002 May; 6(3):191-200. PubMed ID: 12152625 [TBL] [Abstract][Full Text] [Related]
17. Phase III evaluation of four doses of megestrol acetate as therapy for patients with cancer anorexia and/or cachexia. Loprinzi CL; Michalak JC; Schaid DJ; Mailliard JA; Athmann LM; Goldberg RM; Tschetter LK; Hatfield AK; Morton RF J Clin Oncol; 1993 Apr; 11(4):762-7. PubMed ID: 8478668 [TBL] [Abstract][Full Text] [Related]
18. Appetite and appetite stimulants. Shaw C Eur J Cancer Care (Engl); 1993; 2(3):121-4. PubMed ID: 10889628 [TBL] [Abstract][Full Text] [Related]
19. Recent studies of anorexia and appetite stimulation in the cancer patient. Spaulding M Oncology (Williston Park); 1989 Aug; 3(8 Suppl):17-23. PubMed ID: 2701575 [TBL] [Abstract][Full Text] [Related]